Heart Failure Clinical Trial
The Effects of Self-monitoring With a Mobile Application in Heart Failure
Summary
In the United States, about 40 percent of heart failure (HF) patients are readmitted within 1-year following their first admission for HF and hospitalization accounts for approximately 70 percent of the costs of HF management. As a result, the management of HF patients is evolving from the traditional model of face-to-face follow-up visits toward a proactive real-time technological model of assisting patients with monitoring and self-management while in the community. The investigators plan to test the impact of a mobile application on clinical outcomes in HF.
Full Description
HF patients with a reduced ejection fraction will be randomized to the mobile application versus placebo for 12 weeks. The mobile application will provide the participants with a reminder to perform self-monitoring, a health status indicator and heart failure education for self-management.
All participants will complete the Minnesota Living with Heart Failure Questionnaire and Self-Care Heart Failure Index. Hospital admissions and mortality will also be collected.
Eligibility Criteria
Inclusion Criteria:
45 years old or older
Left ventricular ejection fraction = 40% or an LVEF > 40% (with left atrial size >40mm or BNP > 200 pg/ml or NT-proBNP > 800 pg/ml)
Admitted for acutely decompensated heart failure or recently discharged in the past 4 weeks.
Smartphone (iOS or Android) with home wifi
Exclusion Criteria:
Unstable coronary syndrome within 8 weeks (unstable angina, NSTEMI, STEMI)
Primary valvular heart disease
Known pericardial disease (Sarcoidosis, amyloidosis, rheumatoid arthritis, lupus)
Uncorrected thyroid disease
Advanced renal disease (dialysis or creatinine >4.0 mg/dL)
End-stage HF (hospice candidate, home milrinone or dobutamine)
Active cancer
Pulmonary fibrosis
Discharge to a setting other than home
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Ann Arbor Michigan, 48109, United States
Ann Arbor Michigan, 48109, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.